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Abstract 
 
OBJECTIVES: It has been suggested that agitated depression (AD) is a common, severe feature in 
bipolar disorder. We aimed to estimate the prevalence of AD and investigate whether presence of 
AD was associated with episodic and lifetime clinical features in a large well-characterised bipolar 
disorder sample. 
 
METHOD: The prevalence of agitation, based on semi-structured interview and medical case-
notes, in the most severe depressive episode was estimated in 2925 individuals with DSM-IV 
bipolar disorder recruited into the UK Bipolar Disorder Research Network. Predictors of agitation 
were ascertained using symptoms within the same episode and lifetime clinical features using 
multivariate models. 
 
RESULTS: 32.3% (n=946) experienced agitation during the worst depressive episode. Within the 
same episode, significant predictors of presence of agitation were: insomnia (OR 2.119, p<.001), 
poor concentration (OR 1.966, p=.027), decreased libido (OR 1.960, p<.001), suicidal ideation (OR 
1.861, p<.001), slowed activity (OR 1.504, p=.001), and poor appetite (OR 1.297, p=.029). Over the 
lifetime illness course, co-morbid panic disorder (OR 2.000, p<.001), suicide attempt (OR 1.399, 
p=.007), and dysphoric mania (OR 1.354, p=.017) were significantly associated with AD. 
 
CONCLUSIONS: Agitation accompanied bipolar depression in at least one-third of cases in our 
sample and was associated with concurrent somatic depressive symptoms, which are also 
common features of mixed manic states. Furthermore, AD in our sample was associated with 
lifetime experience of mixed mania, in addition to severe lifetime illness course including 
comorbid panic disorder and suicidal behaviour. Our results have implications for the diagnosis 
and treatment of agitated features in bipolar depression. 
 
Keywords: Psychomotor agitation, bipolar disorder, somatic symptoms, panic disorder, suicide, 
mixed features, dysphoric mania, agitated depression. 
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Introduction 
Agitated depression (AD) is a common clinical feature of mood disorders 1,2. Kraepelin 3 and his 
followers classified AD (also called “excited depression”) as a mixed state resulting from the 
combination of opposing polarities of symptoms: mood and thought in the depressive polarity and 
activity in the manic polarity 4. Later, AD was defined through the Research Diagnostic Criteria 
(RDC) as a major depressive episode with psychomotor agitation 5. More recently, Koukopoulos 
and colleagues 6–8 identified AD as mixed depression with two main forms: first, classic agitated 
depression characterized by anxiety and restlessness with motor agitation (in line with RDC 
criteria); and second, depression with inner psychic tension without motor agitation, dominated 
by racing and crowded thoughts, mood lability, spells of weeping and talkativeness. Both forms 
are often characterized by suicidal impulses and sometimes psychotic features. Many authors 
define AD as a major depressive episode with psychomotor agitation and/or the presence of 
excitatory symptoms 9–19 although AD still does not have an unequivocal definition 20 and is 
defined inconsistently across different studies in both unipolar depression and bipolar disorder. 
 
Several studies have investigated the prevalence of AD in bipolar disorder but markedly different 
frequencies have been reported. In bipolar I disorder (BD-I) prevalence estimates of AD vary from 
20% 19 to 50% 7, and from 32% 7 to 41% 12 in bipolar II disorder (BD-II). These studies have been 
performed in relatively small samples, for example, 136 BD-I participants and 417 with BD-II 7, and 
216 with BD-I and 130 with BD-II 18. They also vary substantially in the samples included and the 
definitions of AD 7,10,12,14,16,18,19,21,22. For example, some studies included only patients who had not 
received psycho-pharmacotherapy for the episode of depression before the evaluation 12, while 
other studies included all patients in current treatment for a depressive episode 7,19 but used 
different criteria to assess AD. Maj et al.,19 for example, used the RDC definition 5, whereas 
Koukopoulos et al.,7 included patients with both of their definitions of mixed depression. Other 
studies have focused on patients with AD triggered by antidepressants 22. Most of the published 
research on AD in bipolar disorder has focused only on current illness episodes. In unipolar 
depression, a retrospective approach to assess agitation in previous episodes was taken by Olgiati 
et al.,11 using the operational criteria checklist (OPCRIT,17) , but a similar approach has not been 
carried out in bipolar disorder to date. 
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Some studies have identified demographic and lifetime clinical features associated with the 
presence of AD in bipolar disorder for example, female gender 7,12,19, earlier age at onset 7,12, more 
lifetime mixed episodes 23,24, and suicide attempt history 25,26. In addition, within the same 
depressive episode in bipolar disorder AD has been associated with non-euphoric hypomanic 
symptoms such as distractibility and increased talkativeness 19,21, longer duration of episode 12,19, 
and suicidal ideation 19,21. Therefore, AD appears to be a severe clinical feature in bipolar disorder 
8,13,27. Undetected AD could result in inappropriate treatment 10,14,24, often with dangerous 
outcomes 2,28. In particular, it has been shown that antidepressant therapy in AD increases both 
psychomotor agitation 16,29 and other concurrent excitatory symptoms 30, and as a most serious 
consequence, antidepressants increase the risk of suicide in AD 9,10,23,29,31,32. 
 
A further in-depth investigation of the prevalence and clinical correlates of AD in a large and 
representative sample of individuals with bipolar disorder would have clinical utility for the 
recognition of this serious form of depression in bipolar disorder. Therefore, the present study has 
three main aims: first, to evaluate the prevalence of agitation in the most severe depressive 
episode in a large, well characterized sample of participants with bipolar disorder; secondly, to 
investigate if the presence of AD is associated with other symptoms during the same depressive 
episode; and, thirdly, to explore whether the presence of AD is associated with lifetime clinical 
features. 
 
Patients and methods 
The study was part of our ongoing programme of research into the genetic and non-genetic 
determinants of BD and related mood disorders (Bipolar Disorder Research Network, BDRN; 
bdrn.org) which has UK National Health Service (NHS) Research Ethics Committee approval and 
local Research and Development approval in all participating NHS Trusts/Health Boards. 
 
Participants 
Participants were recruited through NHS psychiatric services, advertisements for volunteers via 
the BDRN website, leaflets, posters, and media coverage about the research and also through the 
service user-led charity, Bipolar UK. 
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All patients in the UK who have a diagnosis of bipolar disorder and are aged 18 years or over are 
eligible to take part in the BDRN research programme and enrol after giving written informed 
consent. The exclusion criteria are individuals who have only experienced affective illness as a 
consequence of alcohol or substance abuse or dependence, and/or who have only experienced 
affective illness as a consequence of medical illness, an organic brain disorder or medication. 
 
Participants in the current study (N= 2925) were those from whom we had information on the 
presence or absence of agitated psychomotor features (defined below) during their worst 
depressive episode who met lifetime DSM-IV diagnostic criteria for BD-I (N= 2011) or BD-II (N= 
914). 
 
Psychiatric assessment 
Lifetime clinical data for each individual were collected by a trained BDRN interviewer (research 
psychologist or psychiatrist) using a semi-structured psychiatric interview, the Schedules for 
Clinical Assessment in Neuropsychiatry (SCAN, 33). Further lifetime clinical data were gathered 
from participants’ psychiatric case notes. Diagnoses and clinical ratings were made using all 
available clinical data according to pre-specified guidelines. OPCRIT 17 was used to assess the 
presence/absence of individual symptoms during the most severe depressive episode. In cases 
where there was doubt, diagnostic and clinical ratings were made by at least two members of the 
research team blind to each other’s ratings and consensus reached via discussion where 
necessary. Inter-rater reliability was formally assessed using 20 random cases. Mean kappa 
statistics were 0.85 for best-estimate lifetime DSM–IV diagnosis and ranged between 0.81 and 
0.99 for other key clinical categorical variables, including OPCRIT ratings. Mean intra-class 
correlation coefficients were between 0.91 and 0.97 for key clinical continuous variables.  
 
Agitated depression (AD) definition 
We defined AD according to the OPCRIT definition, which requires the presence of excessive 
repetitive activity (such as restlessness, wringing of hands, pacing up and down) all usually 
accompanied by expression of mental anguish. In this study, agitation was rated as present/absent 
during the most severe episode of depression using data obtained from the SCAN interview and 
psychiatric case-notes. Our mean kappa statistic for the rating of AD was 0.85. 
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Statistical analysis 
The data were analysed using SPSS version 24. The proportion of the sample with agitation 
present during the worst episode of depression was calculated with 95% confidence intervals (CI). 
The sample was dichotimised into AD-present and AD-absent, and the presence/absence of other 
symptoms in the same episode was compared between the two groups using chi-square tests. All 
symptoms that were significantly different between groups in the univariate analyses (p<.001) 
were included as predictors in a logistic regression model using the enter method with absence or 
presence of AD as the outcome/dependent variable. The p-value was set at p<.001 to account for 
multiple testing and minimise the likelihood of a type 1 error. 
 
Lifetime clinical characteristics and demographics were then compared between the two groups 
(AD-present and AD-absent) using chi-square tests for categorical data and Mann–Whitney U tests 
for continuous data due to significant deviation from normal distributions. A second logistic 
regression analysis (enter method) was conducted. All demographic and lifetime clinical features 
significantly different in the univariate analyses (p<.001) were included as predictors with absence 
or presence of agitated features as the outcome/dependent variable. 
 
Results 
Prevalence of agitated depression 
Almost a third of the episodes of depression met our definition of agitated depression, with 32.3% 
of the sample (946/2925) experiencing agitation during the most severe episode of depression 
(95% CI: 30.6% - 34.0%). 
 
Concurrent depressive episode symptoms according to the presence/absence of agitation 
As reported in Table 1 and shown in Figure 1, compared to individuals without agitation in their 
most severe episode of depression, significantly more individuals with agitation present 
experienced the following seven depressive symptoms during the same episode (p<0.001): i) 
suicidal ideation, ii) excessive self-reproach, iii) poor concentration, iv) slowed activity, v) poor 
appetite, vi) insomnia, and vii) diminished libido. Conversely, significantly fewer individuals with 
agitated features present experienced excessive sleep in the same episode. 
 
- INSERT TABLE 1 HERE – 
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- INSERT FIGURE 1 HERE – 
 
These eight symptoms were included in the logistic regression analysis. The symptoms that 
significantly predicted the presence of concurrent agitated features within the worst episode of 
depression were: insomnia (OR 2.119, 95% C.I: 1.649 – 2.723, p<.001); poor concentration (OR 
1.966, 95% C.I: 1.079 – 3.580, p=.027); diminished libido (OR 1.960, 95% C.I: 1.481 – 2.593, 
p<.001); suicidal ideation (OR 1.861, 95% C.I: 1.323 – 2.618, p<.001); slowed activity (OR 1.504, 
95% C.I: 1.173 – 1.927, p=.001); and, poor appetite (OR 1.297, 95% C.I: 1.027 – 1.639, p=.029). 
This model explained 12.5% of the variance and correctly classified 68.5% of participants as having 
agitated features or not. 
 
Demographic and lifetime clinical features according to the presence/absence of AD 
There was no significant difference in the proportion of males and females between the AD-
present and AD-absent groups, and the age of interview was similar in both groups (see Table 2). 
There were significantly fewer participants who had completed higher education (educated to at 
least Bachelor degree level) in the AD-present group (33.8% v 42.7%).  
 
Compared to the AD-absent individuals, individuals with AD-present had significantly: 
- Higher rate of BD-II (35.5% vs 29.2%, p<.001) 
-            Higher rate of lifetime alcohol misuse (53.1% vs. 44.4%, p<.001) 
- Higher rate of lifetime panic disorder (78.0% vs. 59.0%, p<.001) 
- Higher rate of lifetime dysphoric mania (45.6% vs. 33.8%, p<.001) 
- Higher rate of lifetime ever suicide attempt (41.3% vs. 32.8%, p<.001) 
- Higher rate of rapid cycling over the lifetime illness course (41.9% vs. 33.4%, p<.001) 
- Younger age at illness onset (19 vs. 20 years, p<.001) 
 
- INSERT TABLE 2 HERE – 
 
The demographic and lifetime clinical characteristics that were significantly more common or 
greater in the AD-present group (p<.001) were included in the logistic regression analysis. The 
lifetime clinical characteristics that significantly predicted the presence of AD were: lifetime 
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occurrence of panic disorder (OR 2.000, 95% C.I: 1.527 – 2.618, p<.001); occurrence of at least 
one suicide attempt (OR 1.399, 95% C.I: 1.094 – 1.790, p=.007; and, lifetime occurrence of 
dysphoric mania (OR 1.354, 95% C.I: 1.055 – 1.737, p=.017). This model explained 8.5% of the 
variance and correctly classified 68% of participants as AD-present/absent. We excluded rapid 
cycling from the initial regression due to the high number of cases where a definite rating of the 
absence of rapid cycling could not be made (our definition requires at least 7 years from the onset 
of illness and/or more than 3 affective episodes to give a definite rating of presence/absence), 
which would have reduced the size of the whole sample in the regression model.  However, we 
repeated the regression with a reduced sample size including the rapid cycling variable and the 
significant predictors were the same. 
 
Discussion 
This study is carried out in the largest sample of individuals with bipolar disorder to date. We 
found that AD, defined as psychomotor agitation within the most severe episode of depression, 
was present in almost one-third (32.3%) of individuals in our sample. Although we found a higher 
prevalence of AD in BD-II (36.8 %) than BD-I (30.3 %), lifetime diagnosis was not a significant 
predictor of the presence of AD after controlling for other clinical and socio-demographic features. 
Previous research is not consistent about the prevalence of AD in bipolar disorder 20 probably due 
to the various definitions of AD employed across different studies, including the more extended 
definition of depression with mixed features 34, in addition to heterogeneity between samples. 
However, Judd et al.,16 found a prevalence of 39%, similar to our finding, specifically for 
psychomotor agitation in their bipolar disorder sample. When the prevalence of AD has been 
compared between unipolar depressive disorder and bipolar disorder the results have 
systematically highlighted a higher prevalence of AD in bipolar disorder 2. Interestingly, Olgiati et 
al., 11, using OPCRIT to define AD as we did, found a prevalence of 19% in unipolar depressive 
disorder, so approximately 1 in 5 compared to our rate of approximately 1 in 3 in bipolar disorder. 
Our data strengthen the evidence that agitated activity is a significant feature of bipolar 
depression. 
 
While much of the previous research has focused on the association between agitated features 
and manic symptoms within the same depressive episode 14,28,34, little is known about concurrent 
depressive symptoms associated with AD. From our analysis of a large well-characterised bipolar 
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disorder sample emerges an association between AD and somatic symptoms of depression, 
specifically decreased libido, insomnia, poor appetite, and slowed activity, even after controlling 
for other correlates of AD. Moreover, we found AD was associated with poor concentration and 
suicidal ideation. Consistently, previous research has demonstrated that patients experiencing 
mixed depressive episodes are significantly more likely to have suicidal ideation and suicidal 
behaviour 10,26,35, poor concentration 11,14,19, poor appetite 11 and insomnia 2,7,10. Intriguingly, these 
symptoms are also typical symptoms of a mixed manic episode 23,28,36. Previous literature is not 
consistent regarding the association that we found between concurrent agitated and slowed 
activity. Maj et al., 19 showed slowed activity is more common in non-agitated episodes of 
depression than AD episodes, while in line with our data, Angst et al., 10 reported that both 
agitated activity and slowed activity are often part of the same depressive episode. To the best of 
our knowledge, ours is the first study to demonstrate an association between decreased libido and 
agitated activity. Our within-episode findings could suggest that the presence of agitated activity in 
bipolar depression represents a clinical subtype of bipolar depression with a predominant 
biological aetiology given the association with other physical depressive symptoms (poor appetite, 
slowed activity, diminished libido, insomnia). Further research is needed to examine symptoms of 
both manic and depressive polarity in relation to agitation within episodes of bipolar depression. 
Unfortunately we did not have data on specific manic/hypomanic symptoms concurrent with the 
depressive episode to allow us to examine this. 
 
We found that individuals with bipolar disorder and comorbid lifetime panic disorder were twice as 
likely to experience AD compared to individuals without a history of panic disorder. The 
combination of agitated activity and panic may not be unexpected due to our definition of AD 
where the aspect of psychomotor activation is paramount. Historically, Kraepelin 3 underlined the 
correlation between agitated depressive states and anxiety. Some authors suggested that both 
agitated depression and panic anxiety may be associated with high serum catecholamine level 37. 
Recently this issue has not received great attention, and our study is the first that shows a strong 
association between AD and panic, suggesting that both clinical manifestations could implicate 
similar biological mechanisms, however this matter deserves further study to understand the 
mechanisms of the association. 
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Our data show an association between AD and lifetime dysphoric mania episodes. Our definition of 
dysphoric mania is an episode of mania in which the predominant mood is characterized by 
unease or mental discomfort (including low mood), which is consistent with mixed state definitions 
3,38. Swann et al., 39 examined the clinical manifestations of AD (according to RDC) and dysphoric 
mania, suggesting they are two forms of mixed state both strongly associated with dysphoric mood 
and agitation. Similar to our results they found that AD was most strongly associated with somatic 
symptoms and anxiety, while dysphoric mania was associated with manic thought and hostility. 
Our data suggest that individuals with bipolar disorder who experience AD are also more likely to 
have mixed manic episodes in their lifetime, which is in line with previous research that has 
identified a subtype of bipolar patients characterized by a clinical course of mixed episodes 24,28,32. 
Our finding that agitated activity in bipolar depression is associated with concurrent depressive 
symptoms that have been shown to be common in mixed manic episodes 23,36 (poor concentration, 
poor appetite, insomnia, and suicide behaviour) in other samples is of relevance here, and should 
be examined within the same sample. We do not have detailed symptom data for individual mixed 
manic episodes to be able to examine this in our sample. 
 
It has previously been shown that individuals with bipolar disorder who experience mixed states 
have a more severe illness course with high risk of suicide 20,28. Rihmer and colleagues 25 reported a 
high prevalence of depressive mixed states among suicide attempters, and in particular 
psychomotor agitation is known to be a significant risk factor for suicide 26. Consistent with 
previous research, we found an association between AD and lifetime suicide attempt. Our finding 
within a large sample highlights the need for the detection of agitated features in both past and 
current episodes of depression among individuals with bipolar disorder which could enable 
clinicians to identify those at elevated risk of future suicide attempts. 
 
Our data have clinical relevance for the diagnosis and treatment of AD in bipolar disorder. Our 
finding that specific concurrent depressive symptoms may be associated with psychomotor 
agitation could be useful to identify the manifestation of AD and then target treatment accordingly. 
At the same time, the correlation of specific lifetime clinical features with AD suggests, in 
agreement with previous empirical evidence, that particular care is needed in the pharmacological 
treatment of bipolar depression symptomatology 30,40,41. For example, depressive episodes with 
panic comorbidity are often treated with antidepressants 42, however, the treatment should be 
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closely monitored in order to identify possible psychomotor agitation since such symptomatology 
can worsen with antidepressants 8,16 and, at worst, increase risk of suicide 30,35.  
Moreover, individuals who experience both AD and dysphoric mania during their lifetime could 
belong to a subtype of bipolar disorder characterized by mixed episodes with a high risk of suicide 
attempt for which antidepressant medication is not recommended 23,24.  
Thus, the recognition of psychomotor agitation during bipolar depression may be essential for the 
outcome of the episode and for the overall course of illness.  
Notably, the presence of AD in unipolar depressive disorder has been shown to be associated with 
markers of bipolarity 43,44,45 (subthreshold hypomanic symptoms9,11 and family history of bipolar 
disorder 9,46), therefore, as suggested by Rihmer et al. 47, future research should aim to 
differentiate patients with "pure" unipolar depression from patients with "mixed" or "agitated" 
depression when conducting, for example, clinical trials on antidepressant therapy efficacy or 
genome wide association studies (GWAS) 48. 
 
A potential limitation of our study is the conceptualisation of the term agitated depression. There 
is not a unanimous definition of AD in the literature to date 1,20 and the existence of different 
definitions may affect the estimates of AD prevalence and correlated variables across different 
studies. We used the OPCRIT definition of AD 17, which is consistent with both the original 
Kraepelin definition of AD in which mood and ideation are in the negative polarity and activity in a 
positive polarity 4 and with RDC criteria for AD 5. However, our definition of AD focuses specifically 
on agitated activity and is not compatible with the more extended definition of mixed depression 
that includes agitated thoughts with concurrent manic symptoms in the absence of motor 
agitation 34. We did not have data on other specific manic/hypomanic symptoms concurrent with 
the depressive episode, and thus could not extend our definition. Furthermore, we did not collect 
detailed information on medication taking during the specific episode of AD, so were unable to 
examine the relationship between medication and agitation. In addition, we only had detailed 
symptom ratings for the worst-ever episode of depression for each participant and it is possible 
that in some cases agitated features were only present in other less severe episodes. Therefore our 
prevalence estimate of AD in bipolar disorder is at the lower bound, and the true prevalence is 
likely to be higher. Moreover, our study design only allows us to detect associations between AD 
and other clinical features, without a longitudinal design we cannot infer temporality and causality 
between agitated features and other clinical characteristics of the sample. 
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Nevertheless, this study is the largest to date offering an estimate of the prevalence of AD in 
individuals with a lifetime diagnosis of bipolar disorder and a clear picture of the associations 
between AD and other episodic and lifetime clinical features. It comprehensively brings together 
both novel and previously explored associations of episode and lifetime features with AD using 
systematic and comprehensive methods of clinical assessment exercised by trained researchers 
with a high degree of inter-rater reliability. 
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TABLE 1:  Symptoms present/absent in the most severe episode of depression by the 
presence/absence of agitation 
 
OPCRIT SYMPTOMS, N (%)  
AGITATION PRESENT 
(N=946) 
AGITATION ABSENT 
(N=1979) 
 
 
χ2 (p) 
Loss of pleasure 
Present 
Absent 
 
891 (98.5%) 
             14 (1.5%) 
 
1859 (96.3%) 
       72 (3.7%) 
 
9.974 
(.002) 
Diurnal variation 
(mood worse mornings) 
Present 
Absent 
 
 
458 (52.6%) 
412 (47.4%) 
 
 
935 (49.6%) 
949 (50.4%) 
 
 
2.165 
(.141) 
Suicidal ideation 
Present 
Absent 
 
787 (87.7%) 
110 (12.3%) 
 
1475 (77.2%) 
 435 (22.8%) 
 
43.105 
(<.001) 
Excessive self-reproach 
Present 
Absent 
 
842 (94.5%) 
49 (5.5%) 
 
1682 (90.5%) 
177 (9.5%) 
 
12.916 
(<.001) 
Poor concentration 
Present 
Absent 
 
865 (97.5%) 
22 (2.5%) 
 
1697 (91.3%) 
162 (8.7%) 
 
37.330  
(<.001) 
Slowed activity 
Present 
Absent 
 
567 (69.9%) 
244 (30.1%) 
 
1021 (58.9%) 
711 (41.1%) 
 
28.316 
(<.001) 
Loss of energy 
Present 
Absent 
 
875 (96.3%) 
34 (3.7%) 
 
1809 (94.9%) 
97 (5.1%) 
 
2.524 
(.112) 
Poor appetite 
Present 
Absent 
 
570 (65.6%) 
299 (34.4%) 
 
952 (52.2%) 
873 (47.8%) 
 
43.189 
(<.001) 
Increased appetite 
Present 
Absent 
 
233 (27.6%) 
612 (72.4%) 
 
480 (26.6%) 
   1325 (74.4%) 
 
.282  
(.596) 
Insomnia 
Present 
Absent 
 
538 (77.3%) 
158 (22.7%) 
 
863 (55.2%) 
701 (44.8%) 
 
100.020  
(<.001) 
Excessive sleep 
Present 
Absent 
 
377 (46.1%) 
440 (53.9%) 
 
928 (53.6%) 
804 (46.4%) 
 
12.283 
(<.001) 
Diminished libido 
Present 
Absent 
 
644 (83.0%) 
132 (17.0%) 
 
1188 (70.8%) 
489 (29.2%) 
 
41.414 
(<.001) 
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TABLE 2. Demographic and lifetime clinical features by presence/absence of agitated depression 
 
DEMOGRAPHIC CHARACTERISTICS 
AGITATED DEPRESSION  
PRESENT(N=946) ABSENT(N=1979) 
Sex, n (%) 
Male 
Famale 
 
279 (29.5%) 
667 (70.5%) 
 
639 (32.3%) 
1340 (67.7%) 
 
χ2=2.324 
p=.127 
Educational Attainment, n (%) 
Higher education absent 
Higher education present 
 
584 (66.2%) 
298 (33.8%) 
 
1070 (57.3%) 
 798 (42.7%) 
 
χ2=19.943 
p<.001 
Age at interview in years 
Median 
Interquartile range (IQR) 
 
46 
17(18-83) 
 
46 
19(18-79) 
 
Z=-.283 
p=.777 
LIFETIME CLINICAL FEATURES 
DSM-IV diagnosis, n (%) 
BPI 
BPII 
 
610 (64.5%) 
336 (35.5%) 
 
1401 (70.8%) 
 578 (29.2%) 
 
χ2=11.867 
p<.001 
Cannabinoids regular use, n (%)  
Present 
Absent 
 
666 (74.0%) 
234 (26.0%) 
 
1482 (77.6%) 
 428 (22.4%) 
 
χ2=4.382 
p=.036 
Alcohol misuse †, n (%) 
Present 
Absent 
 
474 (53.1%) 
418 (46.9%) 
 
827 (44.4%) 
1037 (55.6%) 
 
χ2=18.627 
p<.001 
Dysphoric mania ‡, n (%) 
Present 
Absent 
 
349 (45.6%) 
417 (54.4%) 
 
556 (33.8%) 
1091 (66.2%) 
 
χ2=31.075 
p<.001 
Suicide attempt, n (%) 
Present 
Absent 
 
381 (41.3%) 
542 (58.7%) 
 
640 (32.8%) 
1314 (67.2%) 
 
χ2=19.900 
p<.001 
Panic disorder, n (%) 
Present 
Absent 
 
482 (78.0%) 
136 (22.0%) 
 
652 (59.0%) 
454 (41.0%) 
 
χ2=63.864 
p<.001 
Psychosis, n (%) 
Present 
Absent 
 
463 (58.8%) 
325 (41.2%) 
 
962 (56.7%) 
735 (43.3%) 
 
χ2 =.941 
p=.332 
Rapid Cycling §, n (%) 
Present 
Absent 
 
247 (41.9%) 
342 (58.1%) 
 
468 (33.4%) 
932 (66.6%) 
 
χ2=13.030 
p<.001 
Age at illness onset in years ¶, n (%) 
Median 
Interquartile range (IQR) 
 
19  
10(4-64) 
                 
20  
11(4-65) 
 
Z=3.582 
p<.001 
Family history of bipolar disorder ¥, n (%)                                                                                                 
Present                                                                  
Absent 
354 (53.0%) 
314 (47.0%) 
 
692 (49.9%)
694 (50.1%) 
 
χ2 =1.696 
p=.193 
†Alcohol misuse: defined as >14 units in women and >21 units in men per week with related impairment. 
‡ Dysphoric mania: defined as manic episode in which the predominant state was dysphoria, i.e., An unpleasant state 
characterised by unease or mental discomfort including low mood. 
§Rapid cycling: defined as 4 or more affective episodes in one 12 month period. 
¶Age at illness onset: defined as age at which symptoms of affective disorder first caused significant impairment. 
¥ Family history of bipolar disorder: defined as at least one first- or second-degree relative with bipolar I disorder, 
bipolar II disorder, or schizoaffective disorder – bipolar type. 
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Figure 1: Frequency of symptoms present in the worst episode of depression by the 
presence/absence of agitation 
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